The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
The double-stranded RNA activated protein kinase PKR physically associates with the tumor suppressor p53 protein and phosphorylates human p53 on serine 392 in vitro
Abstract
The tumor suppressor p53 is a multifunctional protein that plays a critical role in modulating cellular responses upon DNA damage or other stresses. These functions of p53 are regulated both by protein-protein interactions and phosphorylation. The double-stranded RNA activated protein kinase PKR is a serine/threonine kinase that modulates protein synthesis through the phosphorylation of translation initiation factor eIF-2alpha. PKR is an interferon (IFN)-inducible protein that is thought to mediate the anti-viral and anti-proliferative effects of IFN via its capacity to inhibit protein synthesis. Here we report that PKR physically associates with p53. The interaction of PKR with p53 is enhanced by IFNs and upon conditions that p53 acquires a wild type conformation. PKR/p53 complex formation in vitro requires the N-terminal regulatory domain of PKR and the last 30 amino acids of the C-terminus of human p53. In addition, p53 may function as a substrate of PKR since phosphorylation of human p53 on serine392 is induced by activated PKR in vitro. These novel findings raise the possibility of a functional interaction between PKR and p53 in vivo, which may account, at least in part, for the ability of each protein to regulate gene expression at both the transcriptional and the translational levels.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is known that PKR is physically associated with p53 and phosphorylated it in mouse embryo fibroblasts cells treated with IFN [64].”
From PKR, the double stranded RNA‐dependent protein kinase as a critical target in Alzheimer's disease (2009) · cites this paper as [64]
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Molecular cloning: A laboratory manual
Deininger, P. L. (1990) · Analytical Biochemistry · doi:10.1016/0003-2697(90)90595-z · Cited by 84,684
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
Toshiyuki, M., & Reed, J. C. (1995) · Cell · doi:10.1016/0092-8674(95)90412-3 · Cited by 4,063
p53: puzzle and paradigm.Preprint
Ko, L. J., & Prives, C. L. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,346
pEF-BOS, a powerful mammalian expression vector
Mizushima, S., & Nagata, S. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.17.5322 · Cited by 1,594
A novel form of Epstein-Barr virus latency in normal B cells in vivo
Miyashita, E. M., Yang, B., Lam, K. M. C., Crawford, D., & Thorley‐Lawson, D. A. (1995) · Cell · doi:10.1016/0092-8674(95)90513-8 · Cited by 1,591
Boyle, W. J., van der Geer, P., & Hunter, T. R. (1991) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(91)01013-r · Cited by 1,421
Research works printed but not linked: 1
- Fontoura BM, Sorokina EA, David E and Carroll RB. . 1992 Mol. Cell. Biol. 12: 5145–5151. · DOI
Cited by
Sorted by citations
Randall, R. E., & Goodbourn, S. (2007) · Journal of General Virology · doi:10.1099/vir.0.83391-0 · Cited by 1,609
Post-translational modification of p53 in tumorigenesis
Bode, A. M., & Dong, Z. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1455 · Cited by 1,270
Post‐translational modifications and activation of p53 by genotoxic stresses
Appella, E., & Anderson, C. W. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02225.x · Cited by 1,095
Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures
Goodbourn, S., Didcock, L., & Randall, R. E. (2000) · Journal of General Virology · doi:10.1099/0022-1317-81-10-2341 · Cited by 977
Shieh, S.-Y., Ahn, J., Tamai, K., Taya, Y., & Prives, C. (2000) · Genes & Development · doi:10.1101/gad.14.3.289 · Cited by 972
The eIF2α kinases: their structures and functions
Donnelly, N., Gorman, A. M., Gupta, S., & Samali, A. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1252-6 · Cited by 906
Impact of Protein Kinase PKR in Cell Biology: from Antiviral to Antiproliferative Action
García, M. A., Gil, J., Ventoso, I., Guerra, S., Domingo, E., Rivas, C., & Esteban, M. (2006) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00027-06 · Cited by 818
Koumenis, C., Naczki, C., Koritzinsky, M., Rastani, S., Diehl, J. A., Sonenberg, N., Koromilas, A. E., & Wouters, B. G. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.21.7405-7416.2002 · Cited by 713
Self-citationPKR; a sentinel kinase for cellular stress
Williams, B. R. (1999) · Oncogene · doi:10.1038/sj.onc.1203127 · Cited by 820
The dsRNA protein kinase PKR: Virus and cell control
García, M. A., Meurs, E. F., & Esteban, M. (2007) · Biochimie · doi:10.1016/j.biochi.2007.03.001 · Cited by 644
Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53
Katayama, H. G., Sasai, K., Kawai, H., Yuan, Z.-M., Bondaruk, J. E., Suzuki, F., Fujii, S., Arlinghaus, R. B., Czerniak, B. A., & Sen, S. (2003) · Nature Genetics · doi:10.1038/ng1279 · Cited by 595
Induction of apoptosis by the dsRNA-dependent protein kinase (PKR): Mechanism of action
Gil, J., & Estéban, M. (2000) · APOPTOSIS · doi:10.1023/a:1009664109241 · Cited by 369
Zamanian-Daryoush, M., Mogensen, T. H., DiDonato, J. A., & Williams, B. R. G. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.4.1278-1290.2000 · Cited by 362
CAJAL BODIES: A Long History of Discovery
Cioce, M., & Lamond, A. I. (2005) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.20.010403.103738 · Cited by 372
GPS 5.0: An Update on the Prediction of Kinase-Specific Phosphorylation Sites in Proteins
Wang, C., Xu, H., Lin, S., Deng, W., Zhou, J., Zhang, Y. W., Shi, Y., Peng, D., & Xue, Y. (2020) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2020.01.001 · Cited by 299
Sánchez‐Prieto, R., Rojas, J. M., Taya, Y., & Gutkind, J. S. (2000) · PubMed · Cited by 264
Gal-Ben-Ari, S., Barrera, I., Ehrlich, M., & Rosenblum, K. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00480 · Cited by 274
Qu, L.-K., Huang, S. H., Baltzis, D., Rivas-Estilla, A.-M., Pluquet, O., Hatzoglou, M., Koumenis, C., Taya, Y., Yoshimura, A., & Koromilas, A. E. (2004) · Genes & Development · doi:10.1101/gad.1165804 · Cited by 253
Self-citationCuraxins: Anticancer Compounds That Simultaneously Suppress NF-κB and Activate p53 by Targeting FACT
Gasparian, A. V., Burkhart, C. A., Purmal, A. A., Brodsky, L., Pal, M., Saranadasa, M., Bosykh, D. A., Commane, M., Guryanova, O. A., Pal, S., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002530 · Cited by 242
Dial 9-1-1 for p53: Mechanisms of p53 Activation by Cellular Stress
Ljungman, M. E. (2000) · Neoplasia · doi:10.1038/sj.neo.7900073 · Cited by 222
Initiation Factor eIF2α Phosphorylation in Stress Responses and Apoptosis
Clemens, M. J. (2001) · Progress in molecular and subcellular biology · doi:10.1007/978-3-662-09889-9_3 · Cited by 216
Structure and Function of the Protein Kinase R
Sadler, A. J., & Williams, B. R. G. (2007) · Springer eBooks · doi:10.1007/978-3-540-71329-6_13 · Cited by 203
p53 Signaling and Cell Cycle Checkpoints
Stewart, Z. A., & Pietenpol, J. A. (2001) · Chemical Research in Toxicology · doi:10.1021/tx000199t · Cited by 204
The Role of Protein Kinase R in the Interferon Response
Pindel, A., & Sadler, A. J. (2010) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2010.0099 · Cited by 193
Modular Structure of PACT: Distinct Domains for Binding and Activating PKR
Peters, G. A., Hartmann, R., Qin, J., & Sen, G. C. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.6.1908-1920.2001 · Cited by 178
dsRNA-Dependent Protein Kinase PKR and its Role in Stress, Signaling and HCV Infection
Dabo, S., & MEURS, E. F. (2012) · Viruses · doi:10.3390/v4112598 · Cited by 171
Influenza Virus Infection Increases p53 Activity: Role of p53 in Cell Death and Viral Replication
Turpin, E. A., Luke, K., Jones, J. C., Tumpey, T. M., Konan, K. V., & Schultz‐Cherry, S. (2005) · Journal of Virology · doi:10.1128/jvi.79.14.8802-8811.2005 · Cited by 160
Strategies for manipulating the p53 pathway in the treatment of human cancer
Hupp, T. R., Lane, D. P., & Ball, K. L. (2000) · Biochemical Journal · doi:10.1042/bj3520001 · Cited by 148
Kaufman, R. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.21.11693 · Cited by 142
Cuddihy, A. R., Li, S., Tam, N. W. N., Wong, A. H., Taya, Y., Abraham, N., Bell, J. C., & Koromilas, A. E. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.4.2475 · Cited by 137
Self-citationScheuner, D. L., Patel, R., Wang, F., Lee, K., Kumar, K. U., Wu, J., Nilsson, A., Karin, M., & Kaufman, R. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603784200 · Cited by 137
Dual Role of p53 in Innate Antiviral Immunity
Rivas, C., Aaronson, S. A., & Muñoz‐Fontela, C. (2010) · Viruses · doi:10.3390/v2010298 · Cited by 133
Gil, J., & Estéban, M. (2000) · Oncogene · doi:10.1038/sj.onc.1203710 · Cited by 128
Increased Sensitivity to UV Radiation in Mice with a p53 Point Mutation at Ser389
Bruins, W., Zwart, E., Attardi, L. D., Iwakuma, T., Hoogervorst, E. M., Beems, R. B., Miranda, B., van Oostrom, C. T. M., van den Berg, J., van den Aardweg, G. J., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.20.8884-8894.2004 · Cited by 121
Koromilas, A. E. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.12.007 · Cited by 124
Self-citationInhibition of PACT-Mediated Activation of PKR by the Herpes Simplex Virus Type 1 Us11 Protein
Peters, G. A., Khoo, D., Mohr, I., & Sen, G. C. (2002) · Journal of Virology · doi:10.1128/jvi.76.21.11054-11064.2002 · Cited by 118
Page, G., Rioux Bilan, A., Ingrand, S., Lafay-Chebassier, C., Pain, S., Perault Pochat, M. C., Bouras, C., Bayer, T., & Hugon, J. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.01.047 · Cited by 116
Binding and Nuclear Relocalization of Protein Kinase R by Human Cytomegalovirus TRS1
Hakki, M., Marshall, E. E., Niro, K. L. D., & Geballe, A. P. (2006) · Journal of Virology · doi:10.1128/jvi.00957-06 · Cited by 112
13 The Double-stranded RNA-activated Protein Kinase PKRPreprint
Kaufman, R. J. (2000) · Cold Spring Harbor Monograph Archive · doi:10.1101/087969618.39.503 · Cited by 111
Peel, A. (2003) · Neurobiology of Disease · doi:10.1016/s0969-9961(03)00086-x · Cited by 125
Cdk5 phosphorylates p53 and regulates its activity
Zhang, J., Krishnamurthy, P., & Johnson, G. V. W. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00824.x · Cited by 108
Interferon, a growing cytokine family: 50 years of interferon research
Chelbi‐Alix, M. K., & Wietzerbin, J. (2007) · Biochimie · doi:10.1016/j.biochi.2007.05.001 · Cited by 112
Temporal Gene Regulation During HIV-1 Infection of Human CD4+ T CellsPreprint
Corbeil, J., Sheeter, D. A., Genini, D., Rought, S. E., Leoni, L. M., Du, P., Ferguson, M., Masys, D. R., Welsh, J. B., Fink, J. L., et al. (2001) · Genome Research · doi:10.1101/gr.180201 · Cited by 107
The impact of PKR activation: from neurodegeneration to cancer
Marchal, J. A., López, G., Perán, M., Comino, A., Delgado, J. R., Garcı́a-Garcı́a, J., Conde, V., Aranda, F. M., Rivas, C., Estéban, M., et al. (2014) · The FASEB Journal · doi:10.1096/fj.13-248294 · Cited by 106
Silva, A. M., Whitmore, M., Xu, Z., Jiang, Z., Li, X., & Williams, B. R. G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406554200 · Cited by 103
Xu, Z., & Williams, B. R. G. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.14.5285-5299.2000 · Cited by 113
Castrogiovanni, C., Waterschoot, B., Backer, O. D., & Dumont, P. (2017) · Cell Death and Differentiation · doi:10.1038/cdd.2017.143 · Cited by 100
Chan, S. L., Culmsee, C., Haughey, N. J., Klapper, W., & Mattson, M. P. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0542 · Cited by 99
Clemens, M. J. (2003) · Journal of Interferon & Cytokine Research · doi:10.1089/107999003766628124 · Cited by 96
Cox, M. L., & Meek, D. W. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.11.014 · Cited by 95
Interferons α and γ induce p53-dependent and p53-independent apoptosis, respectively
Porta, C., Hadj-Slimane, R., Nejmeddine, M., Pampin, M., Tovey, M. G., Espert, L., Alvarez, S., & Chelbi‐Alix, M. K. (2004) · Oncogene · doi:10.1038/sj.onc.1208204 · Cited by 97
Li, D. W.-C., Liu, J.-P., Schmid, P. C., Schlosser, R., Feng, H., Liu, W.-B., Yan, Q., Gong, L., Sun, S.-M., Deng, M., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1209334 · Cited by 98
Horton, L. E., Bushell, M., Baus, D., Tilleray, V. J., Clemens, M. J., & Hensold, J. O. (2002) · Oncogene · doi:10.1038/sj.onc.1205662 · Cited by 94
Cesaro, T., & Michiels, T. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.757238 · Cited by 93
Stoichiometric Phosphorylation of Human p53 at Ser315Stimulates p53-dependent Transcription
Blaydes, J. P., Luciani, M. G., Pospı́šilová, Š., Ball, H. M.-L., Vojtesek, B., & Hupp, T. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m003485200 · Cited by 91
Endogenous Double-Stranded RNA
Sadeq, S., Al-Hashimi, S., Cusack, C. M., & Werner, A. (2021) · Non-Coding RNA · doi:10.3390/ncrna7010015 · Cited by 81
Puthenveetil, S., Whitby, L. R., Ren, J., Kelnar, K., Krebs, J., & Beal, P. A. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl464 · Cited by 80
Fanconi anemia type C and p53 cooperate in apoptosis and tumorigenesis
Freie, B. W., Li, X., Ciccone, S. L. M., Nawa, K., Cooper, S. H., Vogelweid, C. M., Schantz, L. D., Haneline, L. S., Orazi, A., Broxmeyer, H. E., et al. (2003) · Blood · doi:10.1182/blood-2003-03-0971 · Cited by 79
Malignant transformation of B lymphoma cell line BJAB by Epstein–Barr virus‐encoded small RNAs
Yamamoto, N., Takizawa, T., Iwanaga, Y., Shimizu, N., & Yamamoto, N. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)02145-1 · Cited by 76
Bergan, V., Jagus, R., Lauksund, S., Kileng, Ø., & Robertsen, B. (2007) · FEBS Journal · doi:10.1111/j.1742-4658.2007.06188.x · Cited by 72
Modulation of the Eukaryotic Initiation Factor 2 α-Subunit Kinase PERK by Tyrosine Phosphorylation
Su, Q., Wang, S., Gao, H. Q., Kazemi, S., Harding, H. P., Ron, D., & Koromilas, A. E. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704612200 · Cited by 71
Self-citationStewart, Z. A., Tang, L. J., & Pietenpol, J. A. (2001) · Oncogene · doi:10.1038/sj.onc.1204060 · Cited by 68
PKR in Innate Immunity, Cancer, and Viral Oncolysis
Balachandran, S., & Barber, G. N. (2007) · Cancer Genomics and Proteomics · doi:10.1007/978-1-59745-335-6_18 · Cited by 65
Ishii, T. M., Kwon, H., Hiscott, J. B., Mosialos, G., & Koromilas, A. E. (2001) · Oncogene · doi:10.1038/sj.onc.1204267 · Cited by 65
Self-citationActivation of the PKR/eIF2α signaling cascade inhibits replication of Newcastle disease virus
Zhang, S., Sun, Y., Chen, H., Dai, Y., Zhan, Y., Yu, S., Qiu, X., Tan, L., Song, C., & Ding, C. (2014) · Virology Journal · doi:10.1186/1743-422x-11-62 · Cited by 63
Role for p53 in Gene Induction by Double-Stranded RNA
Hummer, B. T., Li, X.-L., & Hassel, B. A. (2001) · Journal of Virology · doi:10.1128/jvi.75.16.7774-7777.2001 · Cited by 62
Bennett, R. L., Blalock, W. L., & May, W. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403321200 · Cited by 62
Human papillomaviruses target the double-stranded RNA protein kinase pathway
Hebner, C. M., Wilson, R., Rader, J. S., Bidder, M., & Laimins, L. A. (2006) · Journal of General Virology · doi:10.1099/vir.0.82098-0 · Cited by 60
Chicken interferons, their receptors and interferon-stimulated genes
Goossens, K. E., Ward, A. C., Lowenthal, J. W., & Bean, A. G. D. (2013) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2013.05.020 · Cited by 61
Down-Regulation of p53 by Double-Stranded RNA Modulates the Antiviral Response
Marques, J. T., Rebouillat, D., Ramana, C. V., Murakami, J., Hill, J. E., Gudkov, A. V., Silverman, R. H., Stark, G. R., & Williams, B. R. G. (2005) · Journal of Virology · doi:10.1128/jvi.79.17.11105-11114.2005 · Cited by 58
Synergistic activation of p53-dependent transcription by two cooperating damage recognition pathways
Blaydes, J. P., Craig, A. L., Wallace, M., Ball, H. M.-L., Traynor, N. J., Gibbs, N. K., & Hupp, T. R. (2000) · Oncogene · doi:10.1038/sj.onc.1203773 · Cited by 60
Coukos, G., Makrigiannakis, A., Kang, E. H., Rubin, S. C., Albelda, S. Μ., & Molnar-Kimber, K. L. (2000) · PubMed · Cited by 59
Taylor, D. R., Tian, B., Romano, P. R., Hinnebusch, A. G., Lai, M. M. C., & Mathews, M. B. (2001) · Journal of Virology · doi:10.1128/jvi.75.3.1265-1273.2001 · Cited by 59
Peidis, P., Papadakis, A. I., Muaddi, H., Richard, S., & Koromilas, A. E. (2010) · Cell Death and Differentiation · doi:10.1038/cdd.2010.76 · Cited by 59
Self-citationSong, S., Shi, Y., Wu, W., Wu, H., Chang, L., Peng, P., Zhang, L., Fan, J., Gu, J., & Ruan, Y. (2020) · Gut · doi:10.1136/gutjnl-2020-321386 · Cited by 53
Peters, G. A., Li, S., & Sen, G. C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m607714200 · Cited by 54
Self-citationAnti-apoptotic and oncogenic properties of the dsRNA-binding protein of vaccinia virus, E3L
García, M. Á., Guerra, S., Gil, J., Jiménez, V., & Estéban, M. (2002) · Oncogene · doi:10.1038/sj.onc.1206036 · Cited by 54
Abraham, J., Kelly, J. F., Thibault, P., & Benchimol, S. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3415 · Cited by 54
Modulation of p53 Cellular Function and Cell Death by African Swine Fever Virus
Granja, A. G., Nogal, M. L., Hurtado, C., Salas, J., Salas, M. L., Carrascosa, Á. L., & Revilla, Y. (2004) · Journal of Virology · doi:10.1128/jvi.78.13.7165-7174.2004 · Cited by 52
Spaziani, A., Alisi, A., Sanna, D., & Balsano, C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512536200 · Cited by 50
Tumor Suppressor p53 Mediates Apoptotic Cell Death Triggered by Cyclosporin A
Pyrzyńska, B., Serrano, M., Martínez‐A, C., & Kaminska, B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m104443200 · Cited by 49
Lin, P., Lee, J., Liao, M., Hsu, H., Chiu, S.-J., Liu, H., & Shih, W. (2009) · Virology · doi:10.1016/j.virol.2008.12.028 · Cited by 48
Li, S., & Koromilas, A. E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008140200 · Cited by 48
Self-citation7,12-Dimethylbenz[a]anthracene-Induced Bone Marrow Toxicity Is p53-Dependent
Page, T. J. (2003) · Toxicological Sciences · doi:10.1093/toxsci/kfg115 · Cited by 48
PKR, the double stranded RNA‐dependent protein kinase as a critical target in Alzheimer's disease
Morel, M., Couturier, J., Lafay‐Chebassier, C., Paccalin, M., & Page, G. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00849.x · Cited by 47
Role of PKR and Type I IFNs in Viral Control during Primary and Secondary Infection
Nakayama, Y., Plisch, E. H., Sullivan, J. A., Thomas, C. B., Czuprynski, C. J., Williams, B. R. G., & Suresh, M. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000966 · Cited by 48
Heiber, J. F., & Barber, G. N. (2011) · Journal of Virology · doi:10.1128/jvi.05408-11 · Cited by 48
Tan, S., Tareen, S. U., Melville, M. W., Blakely, C. M., & Katze, M. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205109200 · Cited by 47
Bennett, R. L., Pan, Y., Christian, J., Hui, T., & May, W. S. (2012) · Cell Cycle · doi:10.4161/cc.11.2.18999 · Cited by 45
Interferon-Inducible Protein IFIXα1 Functions as a Negative Regulator of HDM2
Ding, Y., Lee, J.-F., Lu, H., Lee, M., & Yan, D. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.5.1979-1996.2006 · Cited by 44
The Infectious Bursal Disease Virus RNA-Binding VP3 Polypeptide Inhibits PKR-Mediated Apoptosis
Busnadiego, I., Maestre, A. M., Rodrı́guez, D., & Rodrígúez, J. F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046768 · Cited by 44
Couturier, J., Morel, M., Pontcharraud, R., Gontier, V., Fauconneau, B., Paccalin, M., & Page, G. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.041954 · Cited by 44
Protein kinase R and its cellular regulators in cancer: An active player or a surveillant?
Lee, Y. S., Kunkeaw, N., & Lee, Y. (2019) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1558 · Cited by 44
Role for the double-stranded RNA activated protein kinase PKR in E2F-1-induced apoptosis
Vorburger, S. A., Pataer, A., Yoshida, K., Barber, G. N., Xia, W., Chiao, P. J., Ellis, L. M., Hung, M., Swisher, S. G., & Hunt, K. K. (2002) · Oncogene · doi:10.1038/sj.onc.1205761 · Cited by 40
Morel, M., Couturier, J., Pontcharraud, R., Gil, R., Fauconneau, B., Paccalin, M., & Page, G. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.004 · Cited by 36
Itoh, Y., Murata, A., Sakamoto, S., Nanatani, K., Wada, T., Takahashi, S., & Kamagata, K. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.06.001 · Cited by 36
Clinical and therapeutic potential of protein kinase PKR in cancer and metabolism
García‐Ortega, M. B., Lopez, G., Jiménez, G., Garcia-Garcia, J., Conde, V., Boulaiz, H., Carrillo, E., Perán, M., Marchal, J. A., & Garcia, M. (2017) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2017.11 · Cited by 36
Realdon, S., Gerotto, M., Pero, F. D., Marin, O., Granato, A., Basso, G., Muraca, M., & Alberti, A. (2003) · Journal of Hepatology · doi:10.1016/j.jhep.2003.09.017 · Cited by 35
Hoogervorst, E. M., Bruins, W., Zwart, E., van Oostrom, C. T. M., van den Aardweg, G. J., Beems, R. B., van den Berg, J., Jacks, T., STEEG, H. V., & de Vries, A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4328 · Cited by 34
Page, T. J., MacWilliams, P. S., Suresh, M., Jefcoate, C. R. E., & Czuprynski, C. J. (2004) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.02.014 · Cited by 34
Metadata
- Authors
- Cuddihy, A. R., Hoi-Tao Wong, A., Wai Ning Tam, N., Li, S., & Koromilas, A. E.
- Affiliations
- McGill University (CA)
- Venue
- Oncogene
- Published
- 1999-04-28
- Volume
- 18
- Issue
- 17
- Pages
- 2690-2702
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2010358674
- Cited by
- 203
- References
- 68
- Citations by year
- 2026: 2 · 2024: 4 · 2023: 10 · 2022: 4 · 2021: 6 · 2020: 5 · 2019: 6 · 2018: 5 · 2017: 4 · 2016: 5 · 2015: 2 · 2014: 5 · 2013: 7 · 2012: 5
- FWCI
- 6.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- PKR, p53, protein-protein interaction, double-stranded RNA-dependent protein kinase, interferon, tumor suppressor, N-terminal regulatory domain, eIF2α, protein synthesis inhibition, gene expression regulation
- MeSH terms
- Amino Acid Sequence, Animals, Cell Line, Humans, Molecular Sequence Data, Phosphorylation, Precipitin Tests, RNA, Double-Stranded, Serine, Tumor Suppressor Protein p53, Protein Structure, Tertiary, eIF-2 Kinase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review